ANGLE plc (LON:AGL – Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 2.91 and traded as low as GBX 2.33. ANGLE shares last traded at GBX 2.35, with a volume of 1,682,496 shares trading hands.
ANGLE Trading Down 11.3%
The company has a market cap of £7.58 million, a price-to-earnings ratio of -0.49 and a beta of 0.22. The company’s 50 day moving average price is GBX 2.35 and its 200 day moving average price is GBX 2.91. The company has a debt-to-equity ratio of 31.35, a quick ratio of 6.18 and a current ratio of 3.13.
About ANGLE
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Read More
- Five stocks we like better than ANGLE
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.
